跳至主要内容
临床试验/ISRCTN92515063
ISRCTN92515063已完成未知

Cognitive Therapy for Body Dysmorphic Disorder (CT-BDD): a randomized controlled trial

Deutsche Forschungsgemeinschaft (DFG)0 个研究点目标入组 40 人开始时间: 2017年5月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

2022 Results article in https://doi.org/10.1016/j.beth.2022.07.006 (added 14/10/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Primary diagnosis of body dysmorphic disorder (BDD) according to the Body Dysmorphic Disorder Diagnostic Module (BDDDM adapted for DSM-5), the Structured Interview for Diagnostic and Statistical Manual of Mental Disorders – Fifth Edition (SCID-I DSM-5) and the Yale-Brown Obsessive-Compulsive Scale Modified for BDD (BDD-YBOCS) = 20
  • 2. BDD symptoms for at least 6 months prior to participation
  • 3. Age 18-70 years
  • 4. Either no psychotropic medication or, if taking psychotropic medication, be on a stable dose for at least 2 months prior to initial evaluation and agreement not to change the medication during the study
  • 5. Written informed consent

排除标准

  • 1. Acute suicidality
  • 2. Psychotic disorder (excluding delusional BDD)
  • 3. Bipolar disorder
  • 4. Alcohol or substance dependence within the last 3 months
  • 5. Borderline personality disorder
  • 6. Prominent risk of self-harm
  • 7. Body image/weight concerns accounted primarily by an eating disorder
  • 8. Organic mental disorder
  • 9. Severe medical conditions
  • 10. Concurrent psychotherapeutic treatment (e.g., psychodynamic)

研究者

发起方
Deutsche Forschungsgemeinschaft (DFG)

相似试验